UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000030880
Receipt No. R000035249
Official scientific title of the study Examination of 1 week continuous ingestion of drink containing plant extract. A-18001
Date of disclosure of the study information 2018/01/22
Last modified on 2018/07/19 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Examination of 1 week continuous ingestion of drink containing plant extract. A-18001
Title of the study (Brief title) Examination of 1 week continuous ingestion of drink containing plant extract. A-18001
Region
Japan

Condition
Condition Healthy adults
Classification by specialty
Cardiology Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To examine the effects of plant extract on vascular function.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Skin temperature before and after 1day drink ingestion.
Key secondary outcomes Peripheral blood flow and subjective evaluation.

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification NO
Dynamic allocation NO
Institution consideration
Blocking YES
Concealment No need to know

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 Drink containing plant extract (1 week continuous ingestion)->washout period->placebo drink not containing plant extract (1 week continuous ingestion)
Interventions/Control_2 Placebo drink not containing plant extract (1 week continuous ingestion)->washout period->Drink containing plant extract (1 week continuous ingestion)
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
35 years-old >=
Gender Female
Key inclusion criteria 1.Healthy adults
2.Person whose estradiol cycle is stable between 28 and 32 days.
3.Person who is sensitive to cold.
4.Person who agrees not to ingest specified foods and supplements during the test period.
Key exclusion criteria 1.Person whose body math indexes are less than 18.5 or more than 25.0.
2.Person whose diastolic blood pressures are more than 90mmHg and systolic ones are more than 140mmHg.
3.Person who has severe allergic disease as rhinitis, atopicdermatitis.
4.Person who is pregnant, lactating or planned to become pregnant during the test period.
5.Patient with vascular function disorder.
6.Person who has problems with electrocardiogram test such as arrhythmia.
7.Person who takes medicine.
8.Person who regularly goes to hospital or went to the medical institution within a month.
9.Current smoker.
10.Person who plans to participate in the other clinical studies.
11.Person who is judged as unsuitable for the study by the investigator for other reasons.
Target sample size 24

Research contact person
Name of lead principal investigator Akane Suma
Organization Kao Corporation
Division name R&D-Skin Care Products Research
Address 2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, Japan
TEL +81-3-5630-9581
Email suma.akane@kao.com

Public contact
Name of contact person Norio Shimizu
Organization Kao Corporation
Division name R&D-Skin Care Products Research
Address 2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, Japan
TEL +81-465-35-3175
Homepage URL
Email shimizu.norio@kao.com

Sponsor
Institute Kao Corporation
Institute
Department

Funding Source
Organization Kao Corporation
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor SOUKEN Co., Ltd.
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 花王株式会社(東京都)

Other administrative information
Date of disclosure of the study information
2018 Year 01 Month 22 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2017 Year 12 Month 07 Day
Anticipated trial start date
2018 Year 01 Month 23 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2018 Year 01 Month 18 Day
Last modified on
2018 Year 07 Month 19 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035249